Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +1.24% | +4.47% | -61.87% |
13/05 | Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
10/05 | Moleculin Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.87% | 1.08Cr | |
+6.02% | 11TCr | |
+12.24% | 11TCr | |
-12.34% | 2.22TCr | |
-1.31% | 2.13TCr | |
-5.01% | 1.9TCr | |
-35.21% | 1.85TCr | |
-11.16% | 1.68TCr | |
+38.95% | 1.25TCr | |
-25.40% | 808.97Cr |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- Moleculin Biotech Reports Positive Interim Data in Annamycin Trials; Shares Rise